Saffron effects on liver enzymes, antioxidant capacity, insulin, inflammation and genes expression of lipolysis and lipogenesis in a rat model of non-alcoholic fatty liver disease

Saffron effects on liver enzymes, antioxidant capacity, insulin, inflammation and genes expression of lipolysis and lipogenesis in a rat model of non-alcoholic fatty liver disease

Summary: Background and aim: According to increasing attention to the protective effects of saffron in liver disease and increasing prevalence of nonalcoholic fatty liver disease (NAFLD), the present study aimed to investigate the mechanism effects of saffron consumption on treatment of NAFLD in a...

Full description

Bibliographic Details
Main Authors:	Naheed Aryaeian, Roya Alipour, Sahar Jafari Karegar, Mansoreh Soleimani, AghaFatemeh Hosseini, Azita Hekmatdoost
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Clinical Nutrition Open Science
Subjects:	Nonalcoholic fatty liver disease Saffron Liver enzymes PPARα SREBP 1-c
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667268523000736

Similar Items

Saffron regulates bile acid metabolism and participates in the molecular mechanisms of cholestasis-induced liver injury through the mediation of the ERK signaling pathway
by: Wenxiang Wang, et al.
Published: (2024-01-01)

Hepatic G Protein-Coupled Receptor 180 Deficiency Ameliorates High Fat Diet-Induced Lipid Accumulation via the Gi-PKA-SREBP Pathway
by: Yunhua Zhang, et al.
Published: (2023-04-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Fermented Rhus Verniciflua Stokes Extract Alleviates Nonalcoholic Fatty Liver through the AMPK/SREBP1/PCSK9 Pathway in HFD-Induced Nonalcoholic Fatty Liver Animal Model
by: Seon-Ok Lee, et al.
Published: (2020-09-01)

Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention
by: Danny Orabi, et al.
Published: (2021-07-01)

Progesterone increases hepatic lipid content and plasma lipid levels through PR- B-mediated lipogenesis
by: Kang Ju Jeong, et al.
Published: (2024-03-01)

Peroxisome Proliferator-Activated Receptor α Has a Protective Effect on Fatty Liver Caused by Excessive Sucrose Intake
by: Tomomi Yamazaki, et al.
Published: (2022-09-01)

Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway
by: Tingyi Du, et al.
Published: (2022-01-01)

Saffron
by: 8096 British Standards Institution

Effect of Saffron Extract on the Hepatotoxicity Induced by Copper Nanoparticles in Male Mice
by: Azza A. Attia, et al.
Published: (2021-05-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

Melatonin alleviates cadmium-induced nonalcoholic fatty liver disease in ducks by alleviating autophagic flow arrest via PPAR-α and reducing oxidative stress
by: Jian Sun, et al.
Published: (2023-08-01)

Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

<i>Lactobacillus salivarius</i> SNK-6 Regulates Liver Lipid Metabolism Partly via the miR-130a-5p/MBOAT2 Pathway in a NAFLD Model of Laying Hens
by: Lihui Zhu, et al.
Published: (2022-12-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study
by: Gi-Ae Kim, et al.
Published: (2023-12-01)

Current status of liver transplantation for non‐B non‐C liver cirrhosis and hepatocellular carcinoma
by: Takahiro Nishio, et al.
Published: (2023-01-01)

Non-invasive evaluation of liver stiffness in nonalcoholic fatty liver disease: supersonic shear imaging, FibroScan or ARFI?
by: Coskun Ozturker, et al.
Published: (2016-12-01)

Dietary inflammatory index in relation to the progression of hepatic steatosis and liver fibrosis: evaluation by elastography/Fibroscan
by: Mahsa Miryan, et al.
Published: (2024-04-01)

Modifying effects of 2,4-D and Glyphosate exposures on gut-liver-adipose tissue axis of diet-induced non-alcoholic fatty liver disease in mice
by: Guilherme R. Romualdo, et al.
Published: (2023-12-01)

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2024-02-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
by: Jung Hwan Yu, et al.
Published: (2023-02-01)

The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease
by: A. S. Kuznetsova, et al.
Published: (2023-01-01)

Comparative Transcriptomics Analyses in Livers of Mice, Humans, and Humanized Mice Define Human-Specific Gene Networks
by: Chengfei Jiang, et al.
Published: (2020-11-01)

Pathogenetic and clinical significance of the gut-liver microbiota axis
by: D. T. Dicheva, et al.
Published: (2022-05-01)

Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990–2019: a systematic analysis for the GBD 2019
by: Juan Pang, et al.
Published: (2022-08-01)

Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study
by: Noriyo Urata, et al.
Published: (2020-09-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

<i>Beta vulgaris</i> L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPARα
by: Laila Naif Al-Harbi, et al.
Published: (2021-12-01)

Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases
by: Xianhui Zeng, et al.
Published: (2021-07-01)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
by: Yuya Seko, et al.
Published: (2020-10-01)

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
by: Laia Bertran, et al.
Published: (2022-07-01)

Nonalcoholic Fatty Liver Disease and MicroRNAs: A Weighty Consideration
by: Sanjukta Mishra, et al.
Published: (2023-01-01)

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice
by: Takayasu Ideta, et al.
Published: (2015-12-01)

Nonalcoholic fatty liver disease and outcomes in patients with acute coronary syndrome
by: El-Saied Shaheen
Published: (2018-01-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

The association of dietary phytochemical index and nonalcoholic fatty liver disease
by: Bijan Ahmadi, et al.
Published: (2023-07-01)

Alcohol, White Adipose Tissue, and Brown Adipose Tissue: Mechanistic Links to Lipogenesis and Lipolysis
by: Qing Li, et al.
Published: (2023-06-01)

Honokiol Improves Liver Steatosis in Ovariectomized Mice
by: Yeon-Hui Jeong, et al.
Published: (2018-01-01)